Previous Page  13 / 13
Information
Show Menu
Previous Page 13 / 13
Page Background

Advanced Stem Cell 2018

Journal of Stem Cell Biology and Transplantation

ISSN: 2575-7725

Page 48

December 03-04, 2018

Valencia, Spain

15

th

Edition of EuroSciCon Conference on

Advanced Stem Cell &

Regenerative Medicine

K

eratoconjunctivitis sicca (KCS) or dry eye syndrome, is

predominantly immunomediated and dogs are an excellent

model for understanding this disease due to immunomediated

origin similar to that in humans. The objective is to compare the

expression of immunological markers interleukin (IL), IL-1 and

IL-6, tumor necrosis factor alpha (TNFα), and CD4T lymphocytes,

before and after topical treatment with mesenchymal stem

cells (MSC) in KCS in dogs. Twenty-two dogs, with a bilateral

diagnosis of KCS, were treated topically with 50 μl (1x106 MSC)

in the conjunctival sac in 4 applications at 7 day intervals, and

evaluated monthly for 6 months. For analysis of the expression

of IL-1, IL-6, TNFα, and CD4 markers, two collections were

performed, one before and another at the end of the study, by

fine-needle aspiration of the third eyelid gland and processed by

immunocytochemistry and biopsy of the conjunctival palpebral

and processed by immunohistochemistry. The results obtained

through color density showed that at the pre KCS treatment

moment there was a marked expression of all markers (IL-1, IL-

6, TNFα, and CD4) and after 6 months there was a significant

reduction in the marked area of all markers. These results

demonstrated that these markers could be excellent tools for the

diagnosis and progression of KCS and topical treatment of KCS

with MSC was shown to promote a significant decrease in the

expression of these markers after treatment which in future may

represent another adjuvant therapy option in the treatment of KCS

in dogs and humans.

silviafranco@unoeste.br

Expression of immunological markers in the

lacrimal gland and conjunctive palpebral of

dogs with keratoconjunctivitis sicca topically

treated with mesenchymal stem cells

Silvia Franco Andrade

1

, Marcos Rogério Sgrignoli

1

, Danielle Alves Silva

1

, Felipe

Franco Nascimento

1

, Danielle Antonelli Motta

1

, Gisele Alborghetti Nai

2

, Márcia

Guimarães da Silva

3

, Michele Andrade de Barros

4

, Maura Krähembühl Wander-

ley Bittencourt

4

, Heloíse Rangel Dinallo

1

, Bruna Toledo Duran Foglia

1

, Welling-

ton Bott Cabrera

1

and

Elaine Carrion Fares

1

1

University of West of Sao Paulo, Cidade, Brazil

2

University of West of Sao Paulo, Bairro Limoeiro, Brazil

3

Sao Paulo State University, Botucatu, Brazil

4

Regenera, Brazil

J Stem Cell Biol Transplant 2018, Volume 2

DOI: 10.21767/2575-7725-C1-003